| 000 | 01191 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513224424.0 | ||
| 264 | 0 | _c20010103 | |
| 008 | 200101s 0 0 eng d | ||
| 022 | _a0002-9270 | ||
| 024 | 7 |
_a10.1111/j.1572-0241.2000.03325.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArnott, I D | |
| 245 | 0 | 0 |
_aAdministration of infliximab in Crohn's disease does not deplete complement components C3 and C4. _h[electronic resource] |
| 260 |
_bThe American journal of gastroenterology _cNov 2000 |
||
| 300 |
_a3326-7 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aComplement C3 |
| 650 | 0 | 4 | _aComplement C4 |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aShand, A | |
| 700 | 1 | _aGhosh, S | |
| 773 | 0 |
_tThe American journal of gastroenterology _gvol. 95 _gno. 11 _gp. 3326-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1572-0241.2000.03325.x _zAvailable from publisher's website |
| 999 |
_c11036912 _d11036912 |
||